233 results on '"Kollmar, Rainer"'
Search Results
202. COmbination of Targeted temperature management and Thrombectomy after acute Ischemic Stroke (COTTIS): a pilot study.
- Author
-
Bardutzky J, Kollmar R, Al-Rawi F, Lambeck J, Fazel M, Taschner C, and Niesen WD
- Subjects
- Humans, Aged, Pilot Projects, Male, Female, Treatment Outcome, Time Factors, Aged, 80 and over, Middle Aged, Combined Modality Therapy, Recovery of Function, Time-to-Treatment, Prospective Studies, Thrombectomy adverse effects, Feasibility Studies, Hypothermia, Induced adverse effects, Endovascular Procedures adverse effects, Endovascular Procedures instrumentation, Ischemic Stroke therapy, Ischemic Stroke physiopathology, Ischemic Stroke diagnosis, Ischemic Stroke diagnostic imaging
- Abstract
Background: To evaluate the feasibility and safety of a fast initiation of cooling to a target temperature of 35°C by means of transnasal cooling in patients with anterior circulation large vessel occlusion (LVO) undergoing endovascular thrombectomy (EVT)., Methods: Patients with an LVO onset of <24 hour who had an indication for EVT were included in the study. Transnasal cooling (RhinoChill) was initiated immediately after the patient was intubated for EVT and continued until an oesophageal target temperature of 35°C was reached. Hypothermia was maintained with surface cooling for 6-hour postrecanalisation, followed by active rewarming (+0.2°C/hour). The primary outcome was defined as the time required to reach 35°C, while secondary outcomes comprised clinical, radiological and safety parameters., Results: Twenty-two patients (median age, 77 years) were included in the study (14 received additional thrombolysis, 4 additional stenting of the proximal internal carotid artery). The median time intervals were 309 min for last-seen-normal-to-groin, 58 min for door-to-cooling-initiation, 65 min for door-to-groin and 123 min for door-to-recanalisation. The target temperature of 35°C was reached within 30 min (range 13-78 min), corresponding to a cooling rate of 2.6 °C/hour. On recanalisation, 86% of the patients had a body temperature of ≤35°C. The median National Institutes of Health Stroke Scale at admission was 15 and improved to 2 by day 7, and 68% of patients had a good outcome (modified Rankin Scale 0-2) at 3 months. Postprocedure complications included asymptomatic bradycardia (32%), pneumonia (18%) and asymptomatic haemorrhagic transformation (18%)., Conclusion: The combined application of hypothermia and thrombectomy was found to be feasible in sedated and ventilated patents. Adverse events were comparable to those previously described for EVT in the absence of hypothermia. The effect of this procedure will next be evaluated in the randomised COmbination of Targeted temperature management and Thrombectomy after acute Ischemic Stroke-2 trial., Competing Interests: Competing interests: MF is an employee of the company BrainCool., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
203. Contrast-Induced Encephalopathy.
- Author
-
Kollmar R and Biesel J
- Subjects
- Humans, Contrast Media adverse effects, Brain Diseases chemically induced, Brain Diseases diagnostic imaging
- Published
- 2024
- Full Text
- View/download PDF
204. Milestones in the history of neurocritical care.
- Author
-
Kollmar R and De Georgia M
- Abstract
Over the last century, significant milestones have been achieved in managing critical illness and diagnosing and treating neurological diseases. Building upon these milestones, the field of neurocritical care emerged in the 1980 and 1990 s at the convergence of critical care medicine and acute neurological treatment. This comprehensive review presents a historical account of key developments in neurocritical care in both the United States and Europe, with a special emphasis on German contributions. The scope of the review encompasses: the foundations of neurocritical care, including post-operative units in the 1920s and 30s, respiratory support during the poliomyelitis epidemics in the 40 and 50 s, cardiac and hemodynamic care in the 60 and 70 s, and stroke units in the 80 and 90 s; key innovations including cerebral angiography, computed tomography, and intracranial pressure and multi-modal monitoring; and advances in stroke, traumatic brain injury, cardiac arrest, neuromuscular disorders, meningitis and encephalitis. These advances have revolutionized the management of neurological emergencies, emphasizing interdisciplinary teamwork, evidence-based protocols, and personalized approaches to care., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
205. Rapid recovery of poststroke cardiac autonomic dysfunction: Causes to be considered.
- Author
-
Wang R, Moeller S, Akhundova A, Marthol H, Kollmar R, Köhrmann M, and Hilz MJ
- Subjects
- Humans, Middle Aged, Aged, Aged, 80 and over, Autonomic Nervous System, Blood Pressure physiology, Heart, Baroreflex physiology, Heart Rate physiology, Autonomic Nervous System Diseases etiology, Stroke complications
- Abstract
Background and Purpose: Acute stroke frequently causes cardiovascular-autonomic dysfunction (CAD). Studies of CAD recovery are inconclusive, whereas poststroke arrhythmias may wane within 72 h. We evaluated whether poststroke CAD recovers within 72 h upon stroke onset in association with neurological improvement or increased use of cardiovascular medication., Methods: In 50 ischemic stroke patients (68 ± 13 years old) who-prior to hospital-admission-had no known diseases nor took medication affecting autonomic modulation, we assessed National Institutes of Health Stroke Scale (NIHSS) scores, RR intervals (RRIs), systolic and diastolic blood pressure (BP), respiration rate, parameters reflecting total autonomic modulation (RRI SD, RRI total powers), sympathetic modulation (RRI low-frequency powers, systolic BP low-frequency powers), and parasympathetic modulation (square root of mean squared differences of successive RRIs [RMSSD], RRI high-frequency powers), and baroreflex sensitivity within 24 h (Assessment 1) and 72 h after stroke onset (Assessment 2) and compared data to those of 31 healthy controls (64 ± 10 years). We correlated delta NIHSS values (Assessment 1 - Assessment 2) with delta values of autonomic parameters (Spearman rank correlation tests; significance: p < 0.05)., Results: At Assessment 1, patients were not yet on vasoactive medication and had higher systolic BP, respiration rate, and heart rate, that is, lower RRIs, but lower RRI SD, RRI coefficient of variance, RRI low-frequency powers, RRI high-frequency powers, RRI total powers, RMSSDs, and baroreflex sensitivity. At Assessment 2, patients were on antihypertensives, had higher RRI SD, RRI coefficient of variance, RRI low-frequency powers, RRI high-frequency powers, RRI total powers, RMSSDs, and baroreflex sensitivity but lower systolic blood pressure and NIHSS values than at Assessment 1; values no longer differed between patients and controls except for lower RRIs and higher respiration rate in patients. Delta NIHSS scores correlated inversely with delta values of RRI SD, RRI coefficient of variance, RMSSDs, RRI low-frequency powers, RRI high-frequency powers, RRI total powers, and baroreflex sensitivity., Conclusions: In our patients, CAD recovery was almost complete within 72 h after stroke onset and correlated with neurological improvement. Most likely, early initiation of cardiovascular medication and probably attenuating stress supported rapid CAD recovery., (© 2023 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.)
- Published
- 2023
- Full Text
- View/download PDF
206. [Neurointensive care unites neuro-disciplines : Severe nonvascular brain function disorders and syndromes].
- Author
-
Bösel J and Kollmar R
- Subjects
- Humans, Syndrome, Critical Care, Intensive Care Units, Brain, Neurology
- Published
- 2023
- Full Text
- View/download PDF
207. [Erratum to: New aspects in neurointensive and emergency medicine: the most important studies in a review and overview].
- Author
-
Alonso A, Kollmar R, and Dimitriadis K
- Published
- 2022
- Full Text
- View/download PDF
208. [New aspects in neurointensive and emergency medicine: the most important studies in a review and overview].
- Author
-
Alonso A, Kollmar R, and Dimitriadis K
- Subjects
- Humans, Critical Care methods, Anticonvulsants therapeutic use, COVID-19, Subarachnoid Hemorrhage therapy, Emergency Medicine
- Abstract
This review article summarizes the major clinical studies in neurological emergency and intensive care medicine from the end of 2020 to 2021 on the topics: recanalizing treatment in ischemic stroke, usefulness and effect of brain tissue oxygen monitoring in subarachnoid hemorrhage, efficacy of induced hypothermia in patients with cardiac arrest (CA), value of early cranial imaging after CA, relevance of rapid management and effects of different anticonvulsants in status epilepticus and incidence of critical illness polyneuropathy myopathy in intensive care unit patients with COVID-19 infections., (© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
209. Cardiovascular medication seems to promote recovery of autonomic dysfunction after stroke.
- Author
-
Wang R, Köhrmann M, Kollmar R, Koehn J, Schwab S, Kallmünzer B, and Hilz MJ
- Subjects
- Autonomic Nervous System, Baroreflex physiology, Blood Pressure physiology, Female, Heart Rate physiology, Humans, Respiration, Primary Dysautonomias, Stroke complications, Stroke drug therapy
- Abstract
Background: Stroke may compromise cardiovascular-autonomic modulation (CAM). The longitudinal post-stroke CAM alterations remain unclear as previous studies excluded patients with cardiovascular medication. This study evaluated whether CAM dysfunction improves after several months in patients under typical clinical conditions, i.e., without excluding patients with cardiovascular medication., Methods: In 82 ischemic stroke patients [33 women, 64.9 ± 8.9 years, NIHSS-scores 2 (interquartile range 1-5)], we evaluated the applications of cardiovascular medication before stroke, during autonomic tests performed within 1 week, 3 and 6 months after stroke onset. We determined resting RR intervals (RRI), systolic, diastolic blood pressures (BPsys), respiration, parameters reflecting total CAM [RRI-standard deviation (RRI-SD), RRI-total powers], sympathetic [RRI-low-frequency powers (RRI-LF), BPsys-LF powers] and parasympathetic CAM [RMSSD, RRI-high-frequency powers (RRI-HF powers)], and baroreflex sensitivity. ANOVA or Friedman tests with post hoc analyses compared patient data with data of 30 healthy controls, significance was assumed for P < 0.05., Results: More patients had antihypertensive medication after than before stroke. First-week CAM testing showed lower RRIs, RMSSD, RRI-SDs, RRI-total powers, RRI-HF powers, and baroreflex sensitivity, but higher BPsys-LF powers in patients than controls. After 3 and 6 months, patients had significantly higher RRIs, RRI-SDs, RRI-total powers, RMSSDs, RRI-HF powers, and baroreflex sensitivity, but lower BPsys-LF powers than in the 1st week; RMSSDs and RRI-HF powers no longer differed between patients and controls. However, 6-month values of RRIs, RRI-SDs, and baroreflex sensitivity were again lower in patients than controls., Conclusions: Even mild strokes compromised cardiovagal modulation and baroreflex sensitivity. After 3 months, CAM had almost completely recovered. Recovery might be related to the mild stroke severity. Presumably, CAM recovery was also promoted by the increased application of cardiovascular medication. Yet, slight CAM dysfunction after 6 months suggests continuing autonomic vulnerability., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
210. Posterior circulation ischemic stroke not involving the brainstem is associated with cardiovascular autonomic dysfunction.
- Author
-
Wang R, Köhrmann M, Kollmar R, Koehn J, Schwab S, Kallmünzer B, and Hilz MJ
- Subjects
- Autonomic Nervous System, Baroreflex physiology, Blood Pressure physiology, Brain Stem, Heart Rate physiology, Humans, Autonomic Nervous System Diseases etiology, Ischemic Stroke, Stroke complications
- Abstract
Background and Purpose: Ischemic stroke may induce cardiovascular autonomic dysfunction, but most previous studies have included patients with anterior circulation ischemic stroke or brainstem stroke. It remains unclear whether posterior circulation ischemic stroke (PCIS) without brainstem involvement also compromises cardiovascular autonomic modulation (CAM). Therefore, we aimed to assess CAM in PCIS patients with and without brainstem involvement., Methods: In four subgroups of 61 PCIS patients (14 occipital lobe, 16 thalamic, 12 cerebellar, and 19 brainstem strokes) and 30 healthy controls, we recorded RR intervals (RRIs), systolic (SBP) and diastolic blood pressure (DBP), and respiration at supine rest during the first week after stroke onset. We calculated parameters reflecting total CAM (RRI-standard deviation [RRI-SD], RRI-total powers), predominantly sympathetic CAM (RRI-low-frequency [LF] powers and SBP-LF powers] and parasympathetic CAM (root mean square of successive RRI differences [RMSSD], RRI-high-frequency [HF] powers), sympathetic-parasympathetic balance (RRI-LF/HF ratios), and baroreflex sensitivity (BRS). Values were compared among the four PCIS groups and controls using one-way ANOVA Kruskal-Wallis tests, with post-hoc analyses. Significance was assumed for p < 0.05., Results: In each PCIS subgroup, values for RRI, RRI-SD, RMSSD, RRI-HF powers, and BRS were significantly lower, while SBP-LF powers were higher than in the controls. Only in patients with occipital lobe stroke were RRI-LF/HF ratios significantly higher than in controls. Otherwise, autonomic variables did not differ among the four PCIS subgroups., Conclusions: During the first week after stroke onset, our PCIS patients with occipital lobe, thalamic, cerebellar, or brainstem strokes all had reduced cardiovagal modulation, compromised baroreflex, and increased peripheral sympathetic modulation. The RRI-LF/HF ratios suggest that sympathetic predominance is slightly more prominent after occipital lobe stroke. PCIS may trigger cardiovascular autonomic dysfunction even without brainstem involvement., (© 2022 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.)
- Published
- 2022
- Full Text
- View/download PDF
211. Consensus recommendations on therapeutic hypothermia after minimally invasive intracerebral hemorrhage evacuation from the hypothermia for intracerebral hemorrhage (HICH) working group.
- Author
-
Baker TS, Kellner CP, Colbourne F, Rincon F, Kollmar R, Badjatia N, Dangayach N, Mocco J, Selim MH, Lyden P, Polderman K, and Mayer S
- Abstract
Background and Purpose: Therapeutic hypothermia (TH), or targeted temperature management (TTM), is a classic treatment option for reducing inflammation and potentially other destructive processes across a wide range of pathologies, and has been successfully used in numerous disease states. The ability for TH to improve neurological outcomes seems promising for inflammatory injuries but has yet to demonstrate clinical benefit in the intracerebral hemorrhage (ICH) patient population. Minimally invasive ICH evacuation also presents a promising option for ICH treatment with strong preclinical data but has yet to demonstrate functional improvement in large randomized trials. The biochemical mechanisms of action of ICH evacuation and TH appear to be synergistic, and thus combining hematoma evacuation with cooling therapy could provide synergistic benefits. The purpose of this working group was to develop consensus recommendations on optimal clinical trial design and outcomes for the use of therapeutic hypothermia in ICH in conjunction with minimally invasive ICH evacuation., Methods: An international panel of experts on the intersection of critical-care TH and ICH was convened to analyze available evidence and form a consensus on critical elements of a focal cooling protocol and clinical trial design. Three focused sessions and three full-group meetings were held virtually from December 2020 to February 2021. Each meeting focused on a specific subtopic, allowing for guided, open discussion., Results: These recommendations detail key elements of a clinical cooling protocol and an outline for the roll-out of clinical trials to test and validate the use of TH in conjunction with hematoma evacuation as well as late-stage protocols to improve the cooling approach. The combined use of systemic normothermia and localized moderate (33.5°C) hypothermia was identified as the most promising treatment strategy., Conclusions: These recommendations provide a general outline for the use of TH after minimally invasive ICH evacuation. More research is needed to further refine the use and combination of these promising treatment paradigms for this patient population., Competing Interests: Author NB has received research funding from Becton Dickenson, Maryland Industrial Partnerships, Department of Defense. Author TB owns equity in a start-up investigating mechanisms of local cooling for ICH. Authors TB and CK are listed inventors in IP relating to cooling after ICH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer BE declared a shared affiliation with the author PL to the handling editor at the time of review., (Copyright © 2022 Baker, Kellner, Colbourne, Rincon, Kollmar, Badjatia, Dangayach, Mocco, Selim, Lyden, Polderman and Mayer.)
- Published
- 2022
- Full Text
- View/download PDF
212. Leflunomide as Cause of Aseptic Meningitis.
- Author
-
Mäder L, Kollmar R, and Lorenz HM
- Subjects
- Humans, Leflunomide adverse effects, Meningitis, Aseptic chemically induced, Meningitis, Aseptic diagnosis
- Abstract
Competing Interests: The authors declare no conflict of interest.
- Published
- 2021
- Full Text
- View/download PDF
213. Effects of a 4-Step Standard Operating Procedure for the Treatment of Fever in Patients With Acute Stroke.
- Author
-
Lee H, Hedtmann G, Schwab S, and Kollmar R
- Abstract
Background and Purpose: Fever in the acute phase of stroke leads to an unfavorable clinical outcome and increased mortality. However, no specific form of effective fever treatment has been established, so far. We analyzed the effectiveness of our in-house standard operating procedure (SOP) of fever treatment. Methods: This SOP was analyzed for a period of 33 weeks. Patients with cerebral ischemia (ischemic stroke, transient ischemic attack) or cerebral hemorrhage (intracerebral, subarachnoid) and body temperature elevation of ≥ 37.5°C within the first 6 days after admission were eligible for inclusion in the analysis. The results of SOP group, who's data have been collected prospectively were then compared with a historical control group that had been treated conventionally 1 year earlier in the same period. The data of control group have been collected in retrospect. The primary endpoint was the total duration of the fever for the first 6 days after admission to the stroke unit. Results: A total of 130 patients (mean age of 78 ± 12) received 370 antipyretic interventions. Sequential application of paracetamol ( n = 245), metamizole ( n = 53) and calf compress ( n = 15) led to significant reduction in body temperature. In patients who did not respond to these applications, normothermia could be achieved after infusion of the cooled saline solution. Normothermia could be achieved within 120 min in more than 90% of the cases treated by the SOP. The SOP reduced the fever duration in the 6 days significantly, from 12.2 ± 2.7 h [95% confidence interval (CI) for mean] in the control group to 3.9 ± 1.0 h (95% CI) in the SOP group ( p < 0.001). The SOP was rated to be reasonable and effective. Conclusion: Our in-house SOP is cost-efficient and effective for fever treatment in stroke patients, that can be implemented by local health care professionals., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Lee, Hedtmann, Schwab and Kollmar.)
- Published
- 2021
- Full Text
- View/download PDF
214. [Uncomplicated thrombolysis treatment with rt-PA via an intraosseous access after acute ischemic stroke].
- Author
-
Myftiu A, Hedtmann G, and Kollmar R
- Subjects
- Fibrinolytic Agents therapeutic use, Humans, Thrombolytic Therapy, Tissue Plasminogen Activator therapeutic use, Treatment Outcome, Brain Ischemia drug therapy, Ischemic Stroke, Stroke diagnosis, Stroke drug therapy
- Published
- 2020
- Full Text
- View/download PDF
215. A Single Injection of N -Oleoyldopamine, an Endogenous Agonist for Transient Receptor Potential Vanilloid-1, Induced Brain Hypothermia, but No Neuroprotective Effects in Experimentally Induced Cerebral Ischemia in Rats.
- Author
-
Tejada de Rink MM, Naumann U, Kollmar R, Schwab S, Dietel B, Harada H, and Tauchi M
- Subjects
- Animals, Brain metabolism, Dopamine analogs & derivatives, Male, Rats, Rats, Wistar, TRPV Cation Channels metabolism, Brain Ischemia therapy, Hypothermia, Hypothermia, Induced, Neuroprotective Agents pharmacology
- Abstract
Targeted temperature management, or therapeutic hypothermia, is a potent neuroprotective approach after ischemic brain injury. Hypothermia should be induced as soon as possible after the onset of acute stroke to assure better outcomes. Accordingly, drugs with a fast-acting hypothermic effect sustainable through the period of emergency transportation to hospital would have clinical advantages. Activation of the transient receptor potential vanilloid-1 (TRPV1) can induce hypothermia. Our immunohistochemical investigations confirmed that TRPV1 was distributed to perivascular and periventricular regions of the rat brain, where TRPV1 can be easily detected by TRPV1 agonists. An endogenous TRPV1 selective agonist, N -oleoyldopamine (OLDA), and a synthetic antagonist, AMG 9810, were injected intraperitoneally into healthy adult male Wister rats, and brain and core temperatures and gross motor activities were monitored. Comparison with baseline temperatures showed that TRPV1 injection immediately induced mild hypothermia ( p < 0.05 in brain and p < 0.01 in body), and AMG 9810 induced immediate mild hyperthermia (not significant). However, the OLDA-induced hypothermia did not decrease lesion volume after middle carotid artery occlusion in rats. Relative to vehicle, OLDA yielded poorer outcomes and AMG 9810 yielded better outcomes in neurological scores and lesion size. Our study showed that, as an agonist of TRPV1, OLDA has suitable hypothermia-inducing properties, but did not decrease lesion volume. Therefore, the search for novel TRPV1 agonists and/or antagonists providing hypothermia and neuroprotection should continue. Further investigations should also target OLDA-induced transient hypothermia combined with long-term hypothermia maintenance with surface cooling, which mimics the anticipated clinical use of this class of drug.
- Published
- 2020
- Full Text
- View/download PDF
216. [Neuroprotection in neurocritical care].
- Author
-
Kollmar R
- Subjects
- Humans, Brain Injuries therapy, Critical Care methods, Hypothermia, Induced, Neuroprotection, Stroke therapy
- Abstract
In intensive care medicine neuroprotection is understood mostly as various measures to avoid secondary brain damage after initial trauma, as in stroke, intracranial hemorrhage and resuscitation. Every brain trauma differs in the damage pattern and dynamics depending on the primary form of injury. Therefore, there are targeted treatment approaches depending on the pathophysiology of the medical condition. In addition, neuroprotective methods are desirable that are effective in the majority of patients with acute brain injury. In actual fact, in all forms of acute brain injury certain pathophysiological courses are encountered, which can lead to secondary brain damage depending on the intensity, e.g. reperfusion injury, damage to the blood-brain barrier and excitotoxicity. There is evidence to suggest that the creation of physiologically normal conditions leads to a favorable situation for the damaged brain. This article firstly describes the relevance of neuroprotective measures in neurocritical care medicine. Subsequently, general pathophysiological mechanisms in brain trauma are described. Following this, the pathophysiology and treatment options in brain pressure crises (reduction of intracranial pressure), anemia (transfusion management), hyperglycemia and hypoglycemia (adjustment of the blood sugar level) are dealt with. Finally, the use and benefits of therapeutic hypothermia are discussed. This has a special position as the only clinically effective individual measure for neuroprotection. The focus here is on the application following circulatory and cardiac arrest and resuscitation.
- Published
- 2019
- Full Text
- View/download PDF
217. Letter by Neugebauer et al. regarding article "Hypothermia after decompressive hemicraniectomy in treatment of malignant middle cerebral artery stroke: comment on the randomized clinical trial".
- Author
-
Neugebauer H, Schneider H, and Kollmar R
- Subjects
- Decompression, Surgical, Humans, Neurosurgical Procedures, Hypothermia, Infarction, Middle Cerebral Artery
- Published
- 2019
- Full Text
- View/download PDF
218. Is Hypothermia Helpful in Severe Subarachnoid Hemorrhage? An Exploratory Study on Macro Vascular Spasm, Delayed Cerebral Infarction and Functional Outcome after Prolonged Hypothermia.
- Author
-
Kuramatsu JB, Kollmar R, Gerner ST, Madžar D, Pisarčíková A, Staykov D, Kloska SP, Doerfler A, Eyüpoglu IY, Schwab S, and Huttner HB
- Subjects
- Adult, Brain Damage, Chronic etiology, Brain Damage, Chronic prevention & control, Case-Control Studies, Cerebral Angiography, Cerebral Infarction diagnostic imaging, Cerebral Infarction prevention & control, Cerebral Infarction therapy, Critical Care methods, Databases, Factual, Endovascular Procedures, Female, Hospital Mortality, Humans, Hydrocephalus etiology, Hydrocephalus prevention & control, Hydrocephalus surgery, Hypnotics and Sedatives therapeutic use, Length of Stay statistics & numerical data, Male, Middle Aged, Neuromuscular Agents therapeutic use, Perfusion Imaging, Pilot Projects, Prospective Studies, Recovery of Function, Risk, Subarachnoid Hemorrhage complications, Tomography, X-Ray Computed, Treatment Outcome, Ultrasonography, Doppler, Transcranial, Vasospasm, Intracranial diagnostic imaging, Vasospasm, Intracranial prevention & control, Vasospasm, Intracranial therapy, Ventriculoperitoneal Shunt, Cerebral Infarction etiology, Hypothermia, Induced adverse effects, Hypothermia, Induced methods, Subarachnoid Hemorrhage therapy, Vasospasm, Intracranial etiology
- Abstract
Background: Therapeutic hypothermia (TH) is an established treatment after cardiac arrest and growing evidence supports its use as neuroprotective treatment in stroke. Only few and heterogeneous studies exist on the effect of hypothermia in subarachnoid hemorrhage (SAH). A novel approach of early and prolonged TH and its influence on key complications in poor-grade SAH, vasospasm and delayed cerebral ischemia (DCI) was evaluated., Methods: This observational matched controlled study included 36 poor-grade (Hunt and Hess Scale >3 and World Federation of Neurosurgical Societies Scale >3) SAH patients. Twelve patients received early TH (<48 h after ictus), mild (35°C), prolonged (7 ± 1 days) and were matched to 24 patients from the prospective SAH database. Vasospasm was diagnosed by angiography, macrovascular spasm serially evaluated by Doppler sonography and DCI was defined as new infarction on follow-up CT. Functional outcome was assessed at 6 months by modified Rankin Scale (mRS) and categorized as favorable (mRS score 0-2) versus unfavorable (mRS score 3-6) outcome., Results: Angiographic vasospasm was present in 71.0% of patients. TH neither influenced occurrence nor duration, but the degree of macrovascular spasm as well as peak spastic velocities were significantly reduced (p < 0.05). Frequency of DCI was 87.5% in non-TH vs. 50% in TH-treated patients, translating into a relative risk reduction of 43% and preventive risk ratio of 0.33 (95% CI 0.14-0.77, p = 0.036). Favorable functional outcome was twice as frequent in TH-treated patients 66.7 vs. 33.3% of non-TH (p = 0.06)., Conclusion: Early and prolonged TH was associated with a reduced degree of macrovascular spasm and significantly decreased occurrence of DCI, possibly ameliorating functional outcome. TH may represent a promising neuroprotective therapy possibly targeting multiple pathways of DCI development, notably macrovascular spasm, which strongly warrants further evaluation of its clinical impact., (© 2015 S. Karger AG, Basel.)
- Published
- 2015
- Full Text
- View/download PDF
219. EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke.
- Author
-
van der Worp HB, Macleod MR, Bath PM, Demotes J, Durand-Zaleski I, Gebhardt B, Gluud C, Kollmar R, Krieger DW, Lees KR, Molina C, Montaner J, Roine RO, Petersson J, Staykov D, Szabo I, Wardlaw JM, and Schwab S
- Subjects
- Analgesics, Opioid therapeutic use, Anti-Anxiety Agents therapeutic use, Buspirone therapeutic use, Europe, Humans, Logistic Models, Meperidine therapeutic use, Molecular Sequence Data, Outcome Assessment, Health Care methods, Patient Selection, Severity of Illness Index, Treatment Outcome, Brain Ischemia therapy, Clinical Protocols, Hypothermia, Induced methods, Stroke therapy
- Abstract
Rationale: Cooling reduced infarct size and improved neurological outcomes in animal studies modeling ischemic stroke, and also improved outcome in randomized clinical trials in patients with hypoxic-ischemic brain injury after cardiac arrest. Cooling awake patients with ischemic stroke has been shown feasible in phase II clinical trials., Primary Aim: To determine whether systemic cooling to a target body temperature between 34·0 and 35·0°C, started within six-hours of symptom onset and maintained for 24 h, improves functional outcome at three-months in patients with acute ischemic stroke., Design: International, multicenter, phase III, randomized, open-label clinical trial with blinded outcome assessment in 1500 patients aged 18 years or older with acute ischemic stroke and a National Institutes of Health Stroke Scale score of 6 up to and including 18. In patients randomized to hypothermia, cooling to a target body temperature of 34-35°C will be started within six-hours after symptom onset with rapid intravenous infusion of refrigerated normal saline or a surface cooling technique and maintained for 24 h with a surface or endovascular technique. Patients randomized to hypothermia will receive pethidine and buspirone to prevent shivering and discomfort., Primary Outcome: Score on the modified Rankin Scale at 91 days, as analyzed with ordinal logistic regression and expressed as a common odds ratio., Discussion: With 750 patients per intervention group, this trial has 90% power to detect 7% absolute improvement at the 5% significance level. The full trial protocol is available at http://www.eurohyp1.eu. ClinicalTrials.gov Identifier: NCT01833312., (© 2014 World Stroke Organization.)
- Published
- 2014
- Full Text
- View/download PDF
220. Diagnosis of spontaneous cervical artery dissection may be associated with increased prevalence of posttraumatic stress disorder.
- Author
-
Speck V, Noble A, Kollmar R, and Schenk T
- Subjects
- Adaptation, Psychological, Adult, Aortic Dissection psychology, Anxiety diagnosis, Anxiety epidemiology, Cognition, Cost of Illness, Depression diagnosis, Depression epidemiology, Disability Evaluation, Female, Germany epidemiology, Humans, Male, Mental Health, Middle Aged, Prevalence, Prognosis, Prospective Studies, Psychiatric Status Rating Scales, Quality of Life, Retrospective Studies, Risk Factors, Stress Disorders, Post-Traumatic diagnosis, Stress Disorders, Post-Traumatic psychology, Surveys and Questionnaires, Time Factors, Aortic Dissection diagnosis, Aortic Dissection epidemiology, Cervical Vertebrae blood supply, Stress Disorders, Post-Traumatic epidemiology
- Abstract
Background: Receiving information that one has a dissected cervical artery, which can cause a stroke at any time, is obviously traumatic, but details about the psychiatric and psychosocial sequelae are not known. We investigated the prevalence of and risk factors for posttraumatic stress disorder (PTSD) in patients with spontaneous cervical artery dissection (CD) and the impact of PTSD on their psychosocial functioning., Methods: Patients admitted because of CD between 2006 and 2010 were retrospectively examined using a diagnostic PTSD measure (Posttraumatic Diagnostic Scale). Patients between 2011 and 2012 were examined prospectively. To identify potential predictors for PTSD, we examined all patients' stress coping strategies (brief COPE inventory), anxiety and depression (Hospital Anxiety and Depression Scale), impairment by preventive medication, time since diagnosis and their neurologic (modified Rankin Scale) and cognitive status. To identify the psychosocial impact of PTSD, we examined quality of life (Short-Form 36)., Results: Data of 47 retrospectively contacted patients and 15 prospectively examined patients were included. Twenty-eight patients (45.2%) met the diagnostic criteria for PTSD. A significantly reduced health-related quality of life (HRQoL) was found in 27 patients (43.5%) for mental health and in 8 patients (12.9%) for physical health. Results of logistic regression analysis revealed that the use of maladaptive coping strategies was predictive of the disorder (P < .0001). Age, sex, mRS score, impairment caused by medication, and time since diagnosis were not predictive for PTSD. The presence of PTSD itself was the only significant predictor for reduced mental HRQol (P = .0004). Age, sex, mRS score, impairment caused by medication, and total Hospital Anxiety and Depression Scale score were not predictive for reduced mental HRQoL., Conclusions: PTSD seems to occur frequently in patients with CD and is associated with reduced mental HRQoL. Because the presence of a maladaptive coping style is correlated with PTSD, teaching patients better coping skills might be helpful., (Copyright © 2014 National Stroke Association. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
221. Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial.
- Author
-
Ringelstein EB, Thijs V, Norrving B, Chamorro A, Aichner F, Grond M, Saver J, Laage R, Schneider A, Rathgeb F, Vogt G, Charissé G, Fiebach JB, Schwab S, Schäbitz WR, Kollmar R, Fisher M, Brozman M, Skoloudik D, Gruber F, Serena Leal J, Veltkamp R, Köhrmann M, and Berrouschot J
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Diffusion Magnetic Resonance Imaging methods, Female, Filgrastim, Humans, Male, Middle Aged, Radiography, Recombinant Proteins administration & dosage, Recombinant Proteins adverse effects, Recombinant Proteins pharmacokinetics, Time Factors, Brain Infarction diagnostic imaging, Brain Infarction drug therapy, Brain Infarction metabolism, Granulocyte Colony-Stimulating Factor administration & dosage, Granulocyte Colony-Stimulating Factor adverse effects, Granulocyte Colony-Stimulating Factor pharmacokinetics, Stroke diagnostic imaging, Stroke drug therapy, Stroke metabolism
- Abstract
Background and Purpose: Granulocyte colony-stimulating factor (G-CSF; AX200; Filgrastim) is a stroke drug candidate with excellent preclinical evidence for efficacy. A previous phase IIa dose-escalation study suggested potential efficacy in humans. The present large phase IIb trial was powered to detect clinical efficacy in acute ischemic stroke patients., Methods: G-CSF (135 µg/kg body weight intravenous over 72 hours) was tested against placebo in 328 patients in a multinational, multicenter, randomized, and placebo-controlled trial (NCT00927836; www.clinicaltrial.gov). Main inclusion criteria were ≤9-hour time window after stroke onset, infarct localization in the middle cerebral artery territory, baseline National Institutes of Health Stroke Scale score range of 6 to 22, and baseline diffusion-weighted imaging lesion size ≥15 mL. Primary and secondary end points were the modified Rankin scale score and the National Institutes of Health Stroke Scale score at day 90, respectively. Data were analyzed using a prespecified model that adjusted for age, National Institutes of Health Stroke Scale score at baseline, and initial infarct volume (diffusion-weighted imaging)., Results: G-CSF treatment failed to meet the primary and secondary end points of the trial. For additional end points such as mortality, Barthel index, or infarct size at day 30, G-CSF did not show efficacy either. There was, however, a trend for reduced infarct growth in the G-CSF group. G-CSF showed the expected peripheral pharmacokinetic and pharmacodynamic profiles, with a strong increase in leukocytes and monocytes. In parallel, the cytokine profile showed a significant decrease of interleukin-1., Conclusions: G-CSF, a novel and promising drug candidate with a comprehensive preclinical and clinical package, did not provide any significant benefit with respect to either clinical outcome or imaging biomarkers., Clinical Trial Registration Url: http://www.clinicaltrials.gov. Unique identifier: NCT00927836.
- Published
- 2013
- Full Text
- View/download PDF
222. Head and neck cooling decreases tympanic and skin temperature, but significantly increases blood pressure.
- Author
-
Koehn J, Kollmar R, Cimpianu CL, Kallmünzer B, Moeller S, Schwab S, and Hilz MJ
- Subjects
- Aged, Autonomic Nervous System physiology, Cold Temperature, Electrocardiography, Fingers blood supply, Head, Heart Rate physiology, Hemodynamics physiology, Humans, Laser-Doppler Flowmetry, Male, Middle Aged, Neck, Regional Blood Flow, Respiratory Mechanics physiology, Skin blood supply, Skin Temperature, Supine Position, Blood Pressure physiology, Body Temperature physiology, Hypothermia, Induced adverse effects, Hypothermia, Induced methods, Skin Physiological Phenomena, Stroke therapy, Tympanic Membrane physiology
- Abstract
Background and Purpose: Localized head and neck cooling might be suited to induce therapeutic hypothermia in acute brain injury such as stroke. Safety issues of head and neck cooling are undetermined and may include cardiovascular autonomic side effects that were identified in this study., Methods: Ten healthy men (age 35±13 years) underwent 120 minutes of combined head and neck cooling (Sovika, HVM Medical). Before and after onset of cooling, after 60 and 120 minutes, we determined rectal, tympanic, and forehead skin temperatures, RR intervals, systolic and diastolic blood pressures (BP), laser-Doppler skin blood flow at the index finger and cheek, and spectral powers of mainly sympathetic low-frequency (0.04-0.15 Hz) and parasympathetic high-frequency (0.15-0.5 Hz) RR interval oscillations and sympathetic low-frequency oscillations of BP. We compared values before and during cooling using analysis of variance with post hoc analysis; (significance, P<0.05)., Results: Forehead skin temperature dropped by 5.5±2.2°C with cooling onset and by 12.4±3.2°C after 20 minutes. Tympanic temperature decreased by 4.7±0.7°C within 40 minutes, and rectal temperature by only 0.3±0.3°C after 120 minutes. Systolic and diastolic BP increased immediately on cooling onset and rose by 15.3±20.8 mm Hg and 16.5±13.4 mm Hg (P=0.004) after 120 minutes, whereas skin blood flow fell significantly during cooling. RR intervals and parasympathetic RR interval high-frequency powers increased with cooling onset and were significantly higher after 60 and 120 minutes than they were before cooling., Conclusions: Head and neck cooling prominently reduced tympanic temperature and thus might also induce intracerebral hypothermia; however, it did not significantly lower body core temperature. Profound skin temperature decrease induced sympathetically mediated peripheral vasoconstriction and prominent BP increases that are not offset by simultaneous parasympathetic heart rate slowing. Prominent peripheral vasoconstriction and BP increase must be considered as possibly harmful during head and neck cooling.
- Published
- 2012
- Full Text
- View/download PDF
223. A structured reading algorithm improves telemetric detection of atrial fibrillation after acute ischemic stroke.
- Author
-
Kallmünzer B, Breuer L, Hering C, Raaz-Schrauder D, Kollmar R, Huttner HB, Schwab S, and Köhrmann M
- Subjects
- Aged, Aged, 80 and over, Humans, Male, Middle Aged, Prospective Studies, Algorithms, Atrial Fibrillation diagnosis, Atrial Fibrillation etiology, Atrial Fibrillation physiopathology, Brain Ischemia complications, Brain Ischemia diagnosis, Brain Ischemia physiopathology, Electrocardiography methods, Stroke complications, Stroke diagnosis, Stroke physiopathology, Telemetry methods
- Abstract
Background and Purpose: Anticoagulation is a highly effective secondary prevention in patients with cardioembolic stroke and atrial fibrillation/flutter (AF). However, the condition remains underdiagnosed, because paroxysmal AF may be missed by diagnostic tests in the acute phase. In this study, the sensitivity of AF detection was assessed for serial electrocardiographic recordings and continuous stroke unit telemetric monitoring with or without a structured algorithm to analyze telemetric data (SEA-AF)., Methods: Three hundred forty-six consecutive patients with acute ischemic stroke were prospectively included and subjected to standard telemetric monitoring. In addition, telemetric data were separately analyzed following SEA-AF, consisting of a structured evaluation of episodes with high risk for AF and a chronological beat-to-beat screening of the full registration. Serial electrocardiograms were conducted in 24-hour intervals., Results: Median effective telemetry monitoring time was 75.5 hours (interquartile range 64-86 hours). Overall, AF was diagnosed in 119 of 346 patients (34.4%). The structured reading algorithm was the most sensitive method to detected AF. Conventional telemetry and serial electrocardiographic assessments were less effective. However, only 35% of patients with previously documented paroxysmal AF and negative baseline electrocardiogram demonstrated AF episodes during monitoring., Conclusions: Continuous stroke unit telemetry using SEA-AF shows a significantly higher detection rate for AF compared with daily electrocardiographic assessments and standard telemetry without structured reading. The low overall probability to detect paroxysmal AF with either method during the first days after stroke demonstrates the urgent need for complementary diagnostic strategies such as long-term monitoring and frequent follow-up assessments. Clinical Trial Registration- URL: www.clinicaltrials.gov. Unique identifier: NCT01177748.
- Published
- 2012
- Full Text
- View/download PDF
224. Hypothermia and Ischemic Stroke.
- Author
-
Kollmar R and Schwab S
- Abstract
OPINION STATEMENT: The use of tissue plasminogen activator (tPA) is the major treatment method for acute ischemic stroke, but it reaches only a very limited number of stroke patients. Although neuroprotectants may be useful in stroke patients in principle, promising animal data have not yet been successfully transferred to stroke patients. However, many arguments favor the successful translation of therapeutic hypothermia (TH) to stroke patients: it is a multimodal method, there is a strong correlation between fever and outcome in stroke patients, and TH has been shown to be beneficial in other kinds of acute brain injury (resuscitation, perinatal asphyxia). In addition, it is useful in controlling intracranial pressure caused by brain edema. So far, available data from clinical studies are not sufficient to recommend TH for the routine treatment of acute ischemic stroke. The quality of trials and the number of stroke patients treated by TH are far too low to prove efficacy or futility, but multicenter randomized controlled clinical trials are on their way. Studies in awake stroke patients will use TH very early in the clinical setting, which implies certain problems. The use of TH in awake individuals requires methods to suppress cold-induced vegetative responses such as shivering and sympathic activation, clinically relevant side effects that need to be monitored and treated carefully. In mass-occupying ischemic stroke, randomized trials will evaluate the neuroprotective effects of controlling edema and intracranial pressure. Because the optimal depth, duration, and methods of cooling are not clear, only large randomized controlled trials will set the baseline from which TH as a neuroprotective therapy can be optimized and brought successfully to stroke patients.
- Published
- 2012
- Full Text
- View/download PDF
225. Cooling in intracerebral hemorrhage (CINCH) trial: protocol of a randomized German-Austrian clinical trial.
- Author
-
Kollmar R, Juettler E, Huttner HB, Dörfler A, Staykov D, Kallmuenzer B, Schmutzhard E, Schwab S, and Broessner G
- Subjects
- Adolescent, Adult, Aged, Brain Edema etiology, Brain Edema mortality, Brain Edema prevention & control, Cerebral Hemorrhage complications, Cerebral Hemorrhage mortality, Clinical Protocols, Critical Care methods, Double-Blind Method, Endpoint Determination, Female, Humans, Intracranial Pressure physiology, Male, Middle Aged, Prospective Studies, Rewarming, Survival, Survival Rate, Treatment Outcome, Young Adult, Cerebral Hemorrhage therapy, Hypothermia, Induced
- Abstract
Background: Intracerebral hemorrhage accounts for up to 15% of all strokes and is frequently associated with poor functional outcome and high mortality. So far, there is no clear evidence for a specific therapy, apart from general stroke unit or neurointensive care and management of secondary complications. Promising experimental and pilot clinical data support the use of therapeutic hypothermia after intracerebral hemorrhage., Aims: The study aims to determine if therapeutic hypothermia improves survival rates and reduces cerebral lesion volume after large intracerebral hemorrhage compared with conventional treatment., Material and Methods: The Cooling in IntraCerebral Hemorrhage trial is a prospective, multicenter, interventional, randomized, parallel, two-arm (1 : 1) phase II trial with blinded end-point adjudication. Enrolment: 50 patients (age: 18 to 65 years) with large (25 to 64 ml on cranial computertomography), primary intracerebral hemorrhage of the basal ganglia or thalamus within 6 to 18 h after symptom onset are randomly allocated to therapeutic hypothermia for eight-days or conventional temperature management. In the therapeutic hypothermia group, a target temperature of 35.0°C is achieved by endovascular catheters and followed by slow controlled rewarming. Data analysis is based on the intent-to-treat population. The primary outcome measure of the study is the development in total lesion volume on cranial computertomography (intracerebral hemorrhage plus perihemorrhagic edema on day 8 ± 0.5 and day 1 ± 0.5 after intracerebral hemorrhage) and the mortality after 30 days. Secondary end-points are the in-hospital mortality, mortality, and functional outcome (modified Rankin Scale and Barthel-Index) after 90 and 180 days. Safety measures include any adverse events associated with therapeutic hypothermia., Discussion: In the face of a lack of evidence-based therapies for patients with large intracerebral hemorrhage, new promising approaches are desperately needed, but need evaluation in randomized controlled trials., Conclusion: The results of Cooling in IntraCerebral Hemorrhage trial are believed to directly influence future therapy of large intracerebral hemorrhage.
- Published
- 2012
- Full Text
- View/download PDF
226. Temperature management in stroke - an unsolved, but important topic.
- Author
-
Kallmünzer B and Kollmar R
- Subjects
- Acute Disease, Animals, Humans, Body Temperature physiology, Hypothermia, Induced methods, Stroke physiopathology, Stroke therapy
- Abstract
Clinical data clearly show that elevated body temperature contributes to an unfavorable outcome after ischemic and hemorrhagic stroke. Two promising therapeutic strategies arise from this observation: (1) treatment of fever aiming to sustain normothermia and (2) induced hypothermia, targeting core body temperatures below 36.5°C. A limited number of studies investigated antipyretic strategies after acute stroke and their results were rather disappointing in terms of clinical efficacy. For that reason, it remains unproven, whether sufficient fever treatment improves functional outcome. On the other hand, strong experimental evidence supports neuroprotective effects of induced hypothermia after stroke. Yet, clinical data on this topic remain preliminary and rely on a limited number of patients, mostly enrolled in nonrandomized trials. Therefore, induced hypothermia may be considered safe and feasible after ischemic stroke, but little can be said regarding efficacy. This review summarizes the data, both on fever treatment and induced hypothermia following stroke, starting with a synopsis of the most important experimental investigations, leading to the latest clinical trials. Given the promising data and the lack of successful acute neuroprotective therapies available thus far, suggestions are given for future investigation on both topics., (Copyright © 2011 S. Karger AG, Basel.)
- Published
- 2011
- Full Text
- View/download PDF
227. Weight approximation in stroke before thrombolysis: the WAIST-Study: a prospective observational "dose-finding" study.
- Author
-
Breuer L, Nowe T, Huttner HB, Blinzler C, Kollmar R, Schellinger PD, Schwab S, and Köhrmann M
- Subjects
- Aged, Analysis of Variance, Anthropometry, Cerebral Hemorrhage chemically induced, Cerebral Hemorrhage epidemiology, Data Interpretation, Statistical, Dose-Response Relationship, Drug, Female, Fibrinolytic Agents adverse effects, Humans, Injections, Intravenous, Male, Medical Errors, Middle Aged, Odds Ratio, Prospective Studies, Risk Factors, Tissue Plasminogen Activator adverse effects, Treatment Outcome, Body Weight physiology, Fibrinolytic Agents administration & dosage, Fibrinolytic Agents therapeutic use, Stroke drug therapy, Tissue Plasminogen Activator administration & dosage, Tissue Plasminogen Activator therapeutic use
- Abstract
Background and Purpose: Because of the narrow therapeutic range for thrombolysis in stroke, accurate weight-based dosing is essential for efficacy and safety. Stroke patients are frequently incapable to communicate their correct body weight (BW). Thus, dosing is often based on BW estimation, which may lead to dosing errors. The aim of our study was to evaluate availability of BW information, accuracy of estimations, and final dosing of Alteplase (tissue plasminogen activator [tPA]) in a routine clinical setting., Methods: A total of 109 consecutive intravenous thrombolysis patients were prospectively included in the study. Recruitment concluded with 100 complete data sets. Before therapy, BW was estimated independently by 2 physicians, 2 emergency nurses, and a neuroradiological technical assistant. Patients were weighed, and anthropometric measurements for BW approximation were taken. Dosing errors were assessed. Clinical outcome was evaluated at 90 days., Results: Of 109 patients, 55 (50.5%) were unable to provide information on their BW. Of those, 11 (20%) were accompanied by relatives able to give BW information. For all patients, estimation errors rates ranged from 20.8% (patient's own estimation) up to 38.2% (treating physician) and 42.2% (emergency nurse). Finally, 29 patients received an Alteplase dosage diverging >10% from the optimal dose. Twelve were under- and 17 overdosed. Underdosage was an independent predictor for worse outcome in multivariate analysis., Conclusions: Our study shows that reliable BW data are missing for a majority of intravenous thrombolysis patients. Measuring BW before administering Alteplase remains challenging. Given dosing errors in one-third of patients and the observed impact on outcome, standardized weighing before thrombolysis should be considered. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01006434.
- Published
- 2010
- Full Text
- View/download PDF
228. Critical illness polyneuropathy and myopathy in the intensive care unit.
- Author
-
Zink W, Kollmar R, and Schwab S
- Subjects
- Humans, Muscular Diseases physiopathology, Polyneuropathies physiopathology, Respiration, Artificial methods, Intensive Care Units, Muscular Diseases diagnosis, Muscular Diseases therapy, Polyneuropathies diagnosis, Polyneuropathies therapy
- Abstract
Critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) are major complications that occur in severely ill patients who require intensive care treatment. CIP and CIM affect the limb and respiratory muscles, and, as a consequence, they characteristically complicate weaning from the ventilator, increase the length of stay on the intensive care unit, and prolong physical rehabilitation. The basic pathophysiology of both disorders is complex and involves metabolic, inflammatory and bioenergetic alterations. It is unclear at present whether CIP and CIM are distinct entities, or whether they just represent different 'organ' manifestations of a common pathophysiological mechanism. This article provides an overview of the clinical and diagnostic features of CIP and CIM and discusses current pathophysiological and therapeutic concepts relating to these neuromuscular disorders.
- Published
- 2009
- Full Text
- View/download PDF
229. Ketamine followed by memantine for the treatment of major depression.
- Author
-
Kollmar R, Markovic K, Thürauf N, Schmitt H, and Kornhuber J
- Subjects
- Administration, Oral, Depressive Disorder, Major psychology, Drug Administration Schedule, Drug Therapy, Combination, Excitatory Amino Acid Antagonists administration & dosage, Female, Humans, Infusions, Intravenous, Ketamine administration & dosage, Memantine administration & dosage, Middle Aged, Receptors, N-Methyl-D-Aspartate antagonists & inhibitors, Treatment Outcome, Depressive Disorder, Major drug therapy, Excitatory Amino Acid Antagonists therapeutic use, Ketamine therapeutic use, Memantine therapeutic use
- Published
- 2008
- Full Text
- View/download PDF
230. Rise of the machines: controlling the body temperature of critically ill patients by endovascular catheters.
- Author
-
Schwab S and Kollmar R
- Subjects
- Catheterization, Humans, Critical Care, Fever prevention & control, Hypothermia, Induced methods
- Published
- 2004
- Full Text
- View/download PDF
231. Energy expenditure in ischemic stroke patients treated with moderate hypothermia.
- Author
-
Bardutzky J, Georgiadis D, Kollmar R, and Schwab S
- Subjects
- Adult, Aged, Analysis of Variance, Basal Metabolism, Bias, Calorimetry, Indirect standards, Female, Humans, Male, Middle Aged, Nutrition Assessment, Nutritional Status, Oxygen Consumption, Parenteral Nutrition, Total methods, Predictive Value of Tests, Prospective Studies, Respiration, Artificial methods, Serum Albumin metabolism, Statistics, Nonparametric, Time Factors, Brain Ischemia metabolism, Brain Ischemia therapy, Calorimetry, Indirect methods, Energy Metabolism, Hypothermia, Induced methods, Stroke metabolism, Stroke therapy
- Abstract
Objective: To determine total energy expenditure (TEE) in patients with acute ischemic stroke in the territory of the middle cerebral artery (MCA), treated with moderate hypothermia (33 degrees C)., Design and Setting: Prospective study in a neurological ICU., Patients: Ten consecutive patients with severe MCA infarction undergoing moderate hypothermia., Measurements and Results: Indirect calorimetry was performed continuously over the first 6 days after admission. Mean daily TEE decreased significantly from 1549 before initiation of hypothermia to 1099, 1129, and 1157 on the first, second, and third days of hypothermia, respectively and returned to baseline values after hypothermia was terminated. The ratio of TEE to predicted basal energy expenditure declined from 1.01 before induction of hypothermia to an average of 0.74 during steady state of hypothermia and increased to 1.16 after rewarming., Conclusions: We found a significant fall in TEE in sedated, curarized, and ventilated ischemic stroke patients during moderate hypothermia. Indirect calorimetry appears to be a useful tool for measuring energy expenditure in these patients, as predicted basal energy expenditure overestimates the caloric requirements during hypothermia.
- Published
- 2004
- Full Text
- View/download PDF
232. Exogenous brain-derived neurotrophic factor prevents postischemic downregulation of [3H]muscimol binding to GABA(A) receptors in the cortical penumbra.
- Author
-
Sommer C, Kollmar R, Schwab S, Kiessling M, and Schäbitz WR
- Subjects
- Animals, Binding, Competitive drug effects, Binding, Competitive physiology, Brain Ischemia metabolism, Brain Ischemia physiopathology, Brain-Derived Neurotrophic Factor metabolism, Cerebral Cortex metabolism, Cerebral Cortex physiopathology, Cerebral Infarction metabolism, Cerebral Infarction physiopathology, Dizocilpine Maleate pharmacology, Down-Regulation physiology, Excitatory Amino Acid Agonists pharmacology, Excitatory Amino Acid Antagonists pharmacology, GABA Agonists pharmacology, Male, Muscimol pharmacology, Neurons drug effects, Neurons metabolism, Neuroprotective Agents metabolism, Rats, Rats, Wistar, Receptors, GABA-A metabolism, Receptors, N-Methyl-D-Aspartate antagonists & inhibitors, Receptors, N-Methyl-D-Aspartate metabolism, Tritium, alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid pharmacology, Brain Ischemia drug therapy, Brain-Derived Neurotrophic Factor pharmacology, Cerebral Cortex drug effects, Cerebral Infarction drug therapy, Down-Regulation drug effects, Neuroprotective Agents pharmacology, Receptors, GABA-A drug effects
- Abstract
We have previously shown that exogenous application of brain-derived neurotrophic factor (BDNF) reduces infarct volume in the cortical ischemic penumbra after experimental focal ischemia [Stroke 31 (2000) 2212-2217]. Since BDNF is known to modulate the expression and function of various neurotransmitter receptors, we addressed the question whether BDNF may act via modification of postischemic ligand binding to excitatory NMDA and AMPA and/or inhibitory GABA(A) receptors, respectively. Transient focal cerebral ischemia was induced in male Wistar rats for 2 h using the suture occlusion technique. A period of 30 min after occlusion of the middle cerebral artery, BDNF (300 microg/kg per hour in vehicle; n=5) or vehicle alone (n=5) was continuously infused intravenously for 3 h. Using quantitative receptor autoradiography, postischemic ligand binding of [(3)H]MK-801, [(3)H]AMPA and [(3)H]muscimol was analyzed in the ischemic core, the ischemic cortical penumbra and corresponding regions of the contralateral hemisphere. Transient focal ischemia caused a significant reduction of [(3)H]muscimol binding to GABA(A) receptors within the ischemic cortical penumbra of placebo-treated rats. This was largely prevented by exogenous application of BDNF. [(3)H]MK-801 and [(3)H]AMPA binding values were also reduced in the cortical penumbra and the corresponding area of the contralateral hemisphere. Our data suggest that the neuroprotective effect of BDNF against ischemic damage in the cortical penumbra may be mediated in part by maintained activity of the inhibitory GABAergic system which likely counteracts glutamate induced excitotoxicity.
- Published
- 2003
- Full Text
- View/download PDF
233. Influence of inspiration:expiration ratio on intracranial and cerebral perfusion pressure in acute stroke patients.
- Author
-
Georgiadis D, Schwarz S, Kollmar R, Baumgartner RW, and Schwab S
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Monitoring, Physiologic, Respiratory Mechanics, Stroke therapy, Blood Pressure physiology, Cerebrovascular Circulation physiology, Intracranial Pressure physiology, Positive-Pressure Respiration, Stroke physiopathology
- Abstract
Objective: We undertook this study to evaluate the influence of the inspiration:expiration (I:E) ratio on intracranial pressure and cerebral perfusion in patients with acute stroke., Design: Ventilated patients with acute stroke were examined under a protocol involving variations of I:E ratio from 1:2 to 1:1 to 1:2 under positive end-expiratory pressure (PEEP) of 5.3 and - subsequently - 10.6 cmH(2)O. Intracranial pressure was monitored with parenchymal or ventricular catheters. Mean arterial blood pressure, intracranial pressure (ICP), heart rate and peak mean flow velocity of the middle cerebral arteries were continuously recorded., Setting: Neurological intensive care unit., Patients: A total of 45 monitoring sessions were performed in 16 patients (subarachnoid haemorrhage 3, ischemic stroke 13)., Results: No significant changes in any of the parameters monitored were evident in association with the I:E ratio variations under either of the PEEP levels applied. It must be noted, though, that ICP exceeded 15 mmHg in only 5/45 monitoring sessions, and never exceeded 20 mmHg., Conclusions: Our preliminary results suggest that variations of the I:E ratio cause no significant changes in intracranial or cerebral perfusion pressure and, thus, can be safely used in patients with acute stroke without intracranial hypertension. The influence of I:E ratio variations on stroke patients with intracranial hypertension remains to be evaluated.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.